Cargando…

Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis

Oral submucous fibrosis (OSF) is a chronic fibrotic remodeling disease that can progress to oral cancer. However, efficient clinical diagnosis and treatment methods for OSF are still lacking. This study investigated the anti-fibrotic effect of fucoidan on oral fibrosis. To evaluate the fibrotic abil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Chih-Yuan, Chen, Szu-Han, Huang, Chun-Chung, Liao, Yi-Wen, Chao, Shih-Chi, Yu, Cheng-Chia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317791/ https://www.ncbi.nlm.nih.gov/pubmed/35890132 http://dx.doi.org/10.3390/ph15070833

Ejemplares similares

Long non-coding RNA MEG3 promotes fibrosis and inflammatory response in diabetic nephropathy via miR-181a/Egr-1/TLR4 axis
por: Zha, Fangfang, et al.
Publicado: (2019)

LINC00084/miR-204/ZEB1 Axis Mediates Myofibroblastic Differentiation Activity in Fibrotic Buccal Mucosa Fibroblasts: Therapeutic Target for Oral Submucous Fibrosis
por: Lee, Yu-Hsien, et al.
Publicado: (2021)

MiR-424/TGIF2-Mediated Pro-Fibrogenic Responses in Oral Submucous Fibrosis
por: Chou, Ming-Yung, et al.
Publicado: (2023)

LINC00312/YBX1 Axis Regulates Myofibroblast Activities in Oral Submucous Fibrosis
por: Yu, Chuan-Hang, et al.
Publicado: (2020)

Association between MEG3/miR-181b polymorphisms and risk of ischemic stroke
por: Han, Xuemei, et al.
Publicado: (2018)

The functional roles of microRNAs in the pathogenesis of oral submucous fibrosis
por: Hsieh, Pei-Ling, et al.
Publicado: (2022)

Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis
por: Yu, Cheng-Chia, et al.
Publicado: (2021)

miR‐200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2
por: Liao, Yi‐Wen, et al.
Publicado: (2018)

Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition
por: Lin, Ching-Yeh, et al.
Publicado: (2019)

New Insights for Consummate Diagnosis and Management of Oral Submucous Fibrosis Using Reactive and Reparative Fibrotic Parameter Derived Algorithm
por: Ramadoss, Ramya, et al.
Publicado: (2021)

Oral submucous fibrosis: an update
por: Wollina, Uwe, et al.
Publicado: (2015)

Oral submucous fibrosis: An update
por: Ray, Jay Gopal, et al.
Publicado: (2017)

Knockdown of LncRNA NEAT1 inhibits myofibroblast activity in oral submucous fibrosis through miR-760/TPM1 axis
por: Li, Wei, et al.
Publicado: (2022)

Photobiomodulation therapy inhibits oral submucous fibrosis in mice
por: Chiang, Min‐Hsuan, et al.
Publicado: (2020)

Lipid profile in oral submucous fibrosis
por: Mehrotra, Ravi, et al.
Publicado: (2009)

Medical management of oral submucous fibrosis
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2015)

Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation
por: Kamath, Venkatesh Viswanath, et al.
Publicado: (2015)

Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy
por: Shih, Yin-Hwa, et al.
Publicado: (2019)

Activation of AMPK/miR-181b Axis Alleviates Endothelial Dysfunction and Vascular Inflammation in Diabetic Mice
por: Cheng, Chak-Kwong, et al.
Publicado: (2022)

lncRNA MEG3 Downregulation Relieves Intracerebral Hemorrhage by Inhibiting Oxidative Stress and Inflammation in an miR-181b-Dependent Manner
por: Xie, Bo, et al.
Publicado: (2021)

Management of Oral Submucous Fibrosis with Injection of Hyaluronidase and Dexamethasone in Grade III Oral Submucous Fibrosis: A Retrospective Study
por: James, Leena, et al.
Publicado: (2015)

Positive Feedback Loop of SNAIL-IL-6 Mediates Myofibroblastic Differentiation Activity in Precancerous Oral Submucous Fibrosis
por: Peng, Chih-Yu, et al.
Publicado: (2020)

Cardiac fibroblast miR‐27a may function as an endogenous anti‐fibrotic by negatively regulating Early Growth Response Protein 3 (EGR3)
por: Teng, Lifeng, et al.
Publicado: (2020)

Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments
por: Shen, Yen-Wen, et al.
Publicado: (2020)

Exploring Possible Diagnostic Precancerous Biomarkers for Oral Submucous Fibrosis: A Narrative Review
por: You, Jie-Ru, et al.
Publicado: (2023)

Submucous fibrosis of the oral cavity. Histomorphological studies.
por: Wahi, P. N., et al.
Publicado: (1966)

Proliferation and apoptosis markers in oral submucous fibrosis
por: Ranganathan, K, et al.
Publicado: (2011)

Oral submucous fibrosis and its dermatological relation
por: Ali, Fareedi Mukram, et al.
Publicado: (2014)

Pathogenesis and therapeutic intervention of oral submucous fibrosis
por: Yoithapprabhunath, Thukanaykanpalayam Ragunathan, et al.
Publicado: (2013)

Immunohistochemical Analysis of Vimentin in Oral Submucous Fibrosis
por: Nayak, Meghanand T., et al.
Publicado: (2013)

Oral submucous fibrosis and plasma lipid profile
por: Pantvaidya, G. H., et al.
Publicado: (2013)

Oral submucous fibrosis: Are we doing enough?
por: Chugh, Ankita, et al.
Publicado: (2019)

Carcinoma Arising in the Background of Oral Submucous Fibrosis
por: Rangaswamy, Shruthi, et al.
Publicado: (2019)

Evaluation of Hematological Profile in Oral Submucous Fibrosis
por: Abidullah, Mohammed, et al.
Publicado: (2022)

Drug treatment for oral submucous fibrosis: an update
por: Chen, Xueru, et al.
Publicado: (2023)

Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues
por: Yu, Hsin-Hsien, et al.
Publicado: (2018)

MEG3 Regulates CSE-Induced Apoptosis by Regulating miR-421/DFFB Signal Axis
por: Bi, Hui, et al.
Publicado: (2023)

Low Molecular Weight Fucoidan Prevents Radiation-Induced Fibrosis and Secondary Tumors in a Zebrafish Model
por: Wu, Szu-Yuan, et al.
Publicado: (2020)

PTEN and α-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis
por: Monteiro, Roshni, et al.
Publicado: (2021)

MEG2 is regulated by miR-181a-5p and functions as a tumour suppressor gene to suppress the proliferation and migration of gastric cancer cells
por: Liu, Zhijian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q8aq4fnvocfl8t4kbj2jthh3ud